Abiopharma

🔍 Avellan Abel Antonio (Director)

Company: AST SpaceMobile, Inc. (ASTS)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Sold 22,490 shares of Class A Common Stock at $82.87 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 78,574,963.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class C Common Stock (Direct)
  Date: 2026-03-31 | Code: H | shares_owned_after: 78,163,078.00
• Holds 78,163,078 shares of Common Units (Derivative)
  Date: 2026-03-31 | Code: H | shares_owned_after: 78,163,078.00 | Footnotes: F2, F2, F2

Footnotes:

• F1: Represents a payment of tax liability via forfeiture by withholding securities incident to the vesting of Restricted Stock Units representing 61,458 shares of Class A Common Stock issued in accordance with Rule 16b-3, resulting in a net vested number of 38,968 shares. The Reporting Person did not sell any shares.
• F2: The securities reported in this line item represent AST Common Units. At any time on or after April 6, 2022, these AST Common Units may be redeemed by the Reporting Person in exchange for shares of Class A common stock of the Issuer on a one-to-one basis. When a holder of Class C common stock of the Issuer exchanges AST Common Units for shares of Class A common stock of the Issuer, a number of shares of Class C common stock of the Issuer equal to the number of such AST Common Units will be immediately retired by the Issuer and will no longer be outstanding. The AST Common Units do not expire.
• F3: In connection with the closing of the business combination between New Providence Acquisition Corp. and AST & Science, LLC ("AST") on April 6, 2021, each existing common unit previously issued by AST was reclassified and reissued by AST into new Common Units on a 1-to-14.50149869 basis. In addition, each equityholder of Common Units received an equivalent number of Class B Common Stock or Class C Common Stock of the Issuer, as applicable.